Pediatric Drug Development in China: Reforms and Challenges.

[1]  K. Rose,et al.  The Meanings of “Pediatric Drug Development” , 2019, Therapeutic innovation & regulatory science.

[2]  Lili Xu,et al.  Reforming China's drug regulatory system , 2018, Nature Reviews Drug Discovery.

[3]  Yuanli Liu,et al.  A review of promoting access to medicines in China - problems and recommendations , 2018, BMC Health Services Research.

[4]  [Investigation on the rational use of antibacterial agents by Chinese pediatricians in 2016]. , 2018, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[5]  C. Bucci-Rechtweg.  Enhancing the Pediatric Drug Development Framework to Deliver Better Pediatric Therapies Tomorrow. , 2017, Clinical therapeutics.

[6]  C. Giaquinto,et al.  Roles of Clinical Research Networks in Pediatric Drug Development. , 2017, Clinical therapeutics.

[7]  M. Laughon,et al.  Optimizing operational efficiencies in early phase trials: The Pediatric Trials Network experience. , 2016, Contemporary clinical trials.

[8]  Hidefumi Nakamura,et al.  Improvement of Pediatric Drug Development: Regulatory and Practical Frameworks. , 2016, Clinical therapeutics.

[9]  J. Marriott,et al.  Paediatric pharmacokinetics: key considerations. , 2015, British journal of clinical pharmacology.

[10]  Tao Xing-r.  Investigation on Off-label Drug Use in Hospitalized Children of Our Hospital , 2015 .

[11]  P. Smith,et al.  Dosing in neonates: special considerations in physiology and trial design , 2015, Pediatric Research.

[12]  C. Giaquinto,et al.  Paediatric drug development: the impact of evolving regulations. , 2014, Advanced drug delivery reviews.

[13]  Yi Wang,et al.  Current Status of Pediatric Labeling in China and the near Future Efforts Needed for the Country , 2014, Front. Pediatr..

[14]  Guo Chun-ya.  A survey of Off-label Drug Use Prescriptions in Outpatient of Beijing Children's Hospital , 2014 .

[15]  Munir Pirmohamed,et al.  Adverse drug reactions and off-label and unlicensed medicines in children: a nested case?control study of inpatients in a pediatric hospital , 2013, BMC Medicine.

[16]  Juan Lv,et al.  Pediatric off‐label drug use in China: risk factors and management strategies , 2013, Journal of evidence-based medicine.

[17]  Aaron Sachs,et al.  Pediatric information in drug product labeling. , 2012, JAMA.

[18]  E. Kimland,et al.  Off‐Label Drug Use in Pediatric Patients , 2012, Clinical pharmacology and therapeutics.

[19]  Jörg Breitkreutz,et al.  Paediatric and geriatric drug delivery , 2007, Expert opinion on drug delivery.

[20]  R. Gorman.  The march toward rational therapeutics in children , 2003, The Pediatric infectious disease journal.

[21]  D. Murphy,et al.  Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. , 2003, JAMA.